Brain-derived neurotrophic factor (
BDNF), the TrkB
ligand, is associated with aggressive malignant behavior, including migration and invasion, in
tumor cells and a poor prognosis in patients with various types of
cancer.
Delphinidin is a diphenylpropane-based polyphenolic ring structure-harboring compound, which exhibits a wide range of pharmacological activities, anti-
tumor,
anti-oxidant, anti-inflammatory, anti-angiogenic and anti-mutagenic activity. However, the possible role of
delphinidin in the
cancer migration and invasion is unclear. We investigated the suppressive effect of
delphinidin on the
cancer migration and invasion. Thus, we found that
BDNF enhanced
cancer migration and invasion in SKOV3
ovarian cancer cell. To exam the inhibitory role of
delphinidin in SKOV3
ovarian cancer migration and invasion, we investigated the use of
delphinidin as inhibitors of
BDNF-induced motility and invasiveness in SKOV3
ovarian cancer cells in vitro. Here, we found that
delphinidin prominently inhibited the
BDNF-induced increase in cell migration and invasion of SKOV3
ovarian cancer cells. Furthermore,
delphinidin remarkably inhibited
BDNF-stimulated expression of MMP-2 and MMP-9. Also,
delphinidin antagonized the phosphorylation of Akt and nuclear translocation of NF-κB permitted by the
BDNF in SKOV3
ovarian cancer cells. Taken together, our findings provide new evidence that
delphinidin suppressed the
BDNF-induced
ovarian cancer migration and invasion through decreasing of Akt activation.